Grifola frondosa (Dicks.: Fr.) S.F. Gray (maitake mushroom): Medicinal properties, active compounds, and biotechnological cultivation

International Journal of Medicinal Mushrooms

Volumn 9, Issue 2, 2007, Pages 89-108

  Boh, Bojana ^a   Berovic, Marin ^a  

^a UNIVERSITY OF LJUBLJANA   (Slovenia)

Author keywords

Active compounds; Cultivation; Grifola frondosa; Maitake mushroom; Medicinal effects

Indexed keywords

BETA 1,3 GLUCAN; BETA 1,6 GLUCAN; BETA GLUCAN; CARMUSTINE; CISPLATIN; ETOPOSIDE; FINASTERIDE; FLUOROURACIL; FLUTAMIDE; GLYCOPROTEIN; GRIFOLA FRONDOSA EXTRACT; GRIFOLAN; METHOTREXATE; MITOMYCIN C; PLANT EXTRACT; POLYSACCHARIDE; UNCLASSIFIED DRUG; VANCOMYCIN; YOGHURT;

ANGIOGENESIS; ANTIBACTERIAL ACTIVITY; ANTIHYPERTENSIVE ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; ANTIVIRAL ACTIVITY; ARTHRITIS; ARTICLE; BACTERIAL INFECTION; BIOREACTOR; BREAST CANCER; CANCER CELL CULTURE; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER PATIENT; CELL VIABILITY; CYTOTOXICITY; DIABETES MELLITUS; DIETARY INTAKE; DRUG ACTIVITY; DRUG CLEARANCE; DRUG EFFECT; DRUG EFFICACY; DRUG ISOLATION; DRUG MECHANISM; DRUG METABOLISM; GLUCOSE BLOOD LEVEL; GRIFOLA; GRIFOLA FRONDOSA; HEPATITIS B; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERTENSION; IMMUNOMODULATION; IMMUNOSTIMULATION; INFECTION PREVENTION; INNATE IMMUNITY; ION EXCHANGE CHROMATOGRAPHY; LIPID METABOLISM; LIQUID CULTURE; LISTERIA MONOCYTOGENES; LISTERIOSIS; MEDICINAL PLANT; MUSHROOM; MYCELIUM; NATURAL KILLER CELL; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PROSTATE CANCER; PROSTATE HYPERTROPHY; STRUCTURE ACTIVITY RELATION; VIRUS INFECTION;

BASIDIOMYCOTA; GRIFOLA FRONDOSA;

EID: 34347357541     PISSN: 15219437     EISSN: None     Source Type: Journal    
DOI: 10.1615/IntJMedMushr.v9.i2.10     Document Type: Article

References (99)

1. Adachi K., Nanba H., and Kuroda H. 1987. Potentiation of host-mediated antitumor activity in mice by beta-glucan obtained from Grifola frondosa (Maitake). Chem Pharm Bull, 35, 262-270.
2. Adachi K., Nanba H., Otsuka M., and Kuroda H. 1988a. Blood pressure-lowering activity present in the fruit body of Grifola frondosa (maitake). Chem Pharm Bull (Tokyo), 36, 1000-1006.
3. Adachi Y., Ohno N., and Yadomae T. 1988b. Degradation with formic acid of conformationally different (1→3)-β-D-glucans isolated from liquid-cultured mycelium of Grifola frondosa. Carbohydr Res, 177, 91-100.
4. Bae J. T., Sim G. S., Lee D. H., Lee B. C., Pyo H. B., Choe T. B., and Yun J. W. 2005. Production of exopolysaccharide from mycelial culture of Grifola frondosa and its inhibitory effect on matrix metalloproteinase-1 expression in UV-irradiated human dermal fibroblasts. FEMS Microbiol Lett, 251, 347-354.
5. Barry R. J., Govindan G., and Miller A. 2003. Grifola extracts and methods of use thereof. Patent application PCT WO 03/011217 A2.
6. Borchers A. T., Stern J. S., Hackman R. M., Keen C. L., and Gershwin M. E. 1999. Mushrooms, tumors, and immunity. Proc Soc Exper Biol Med, 221, 281-293.
7. Chen A. 2001. Maitake at a glance. MushWorld [serial on the Internet], 2001 Aug 01. Available from: http://www.mushworld.com/.
8. Chen A. 2004. Crop management and morphogenesis of Grifola frondosa (Maitake) in cultivation. MushWorld [serial on the Internet], 2004 Apr 09, Available from: http://www.mushworld.com/.
9. Chen A. W., Stamets P., Huang H. L., and Han S. H. 1999. Maitake cultivation at a glance - Parts I, II. The Mushroom Growers' Newsletter (USA), 1999 Sept-Oct. Available from: http://www.mushroom company.com/.
10. Choi H. S., Cho H. Y., Yang H. C., Ra K. S., and Suh H. J. 2001. Angiotensin 1-converting enzyme inhibitor from Grifola frondosa. Food Res Int, 34, 177-182.
11. Cui F. J., Li Y., Xu Z. H., Xu H. Y., Sun K., and Tao W. Y. 2006. Optimization of the medium composition for production of mycelial biomass and exo-polymer by Grifola frondosa GF9801 using response surface methodology. Bioresour Technol, 10, 1209-1216.
12. Cui F. J., Tao W. Y., Xu Z. H., Guo W. J., Xu H. Y., Ao Z. H., Jin J., and Wei Y. Q. 2007. Structural analysis of anti-tumor heteropolysaccharide GFPS1b from the cultured mycelia of Grifola frondosa. Bioresour Technol, 98, 395-401.
13. Du Y., Gu G., Hua Y., Wei G., Yeb X., and Yuc G. 2004. Synthesis and antitumor activities of glucan derivatives. Tetrahedron, 60, 6345-6351.
14. Finkelstein M. P., Aynehchi S., Samadi A. A., Drinis S., Choudhury M. S., Tazaki H., and Konno S. 2002. Chemosensitization of carmustine with maitake beta-glucan on androgen-independent prostatic cancer cells: involvement of glyoxalase I. J Altern Complement Med, 8, 573-580.
15. Frank J. A., Xiao R., Yu S., Ferguson M., Hennings L. J., Simpson P. M., Ronis M. J. J., Fang N., Badger T. M., and Simmen F. A. 2006. Effect of Shiitake mushroom dose on colon tumorigenesis in azoxymethane-treated male sprague-dawley rats. Nutr Res, 26, 138-145.
16. Fukunaga K., Takemura K., Kariya Y., and Kondo M. 1991. Method for cultivating mushroom and apparatus used therefore. Patent JP 3172118.
17. Fukushima M., Ohashi T., Fujiwara Y., Sonoyama K., and Nakano M. 2001. Cholesterol-lowering effects of Maitake (Grifola frondosa) fiber, Shiitake (Lentinus edodes) fiber, and Enokitake (Flammulina velutipes) fiber in rats. Exp Biol Med, 226, 758-765.
18. Harada N., Kodama N., and Nanba H. 2003. Relationship between dendritic cells and the D-fraction-induced Th-1 dominant response in BALB/c tumor-bearing mice. Cancer Lett, 192, 181-187.
19. Healy V., O'Connell J., McCarthy V., and Doonan S. 1999. The lysine-specific proteinase from Armillaria mellea is a member of a novel class of metalloendopeptidases located in Basidiomycetes. Biochem Biophys Res Commun, 262, 60-63.
20. Hideo N. 1985. Artificial cultivation of aerobic fungus. Patent JP 60259180.
21. Hishida I., Nanba H., and Kuroda H. 1988. Antitumor activity exhibited by orally administered extract from fruit body of Grifola frondosa (Maitake). Chem Pharm Bull (Tokyo), 36, 1819-1827.
22. Hsieh C., Liu C. J., Tseng M. H., Lo C. T., and Yang Y. C. 2006. Effect of olive oil on the production of mycelial biomass and polysaccharides of Grifola frondosa under high oxygen concentration aeration. Enzyme Microb Tech, 39, 434-439.
23. Iino K., Ohno N., Suzuki I., Miyazaki T., and Yadomae T. 1985. Structural characterization of a neutral antitumour β-D-glucan extracted with hot sodium hydroxide from cultured fruit bodies of Grifola frondosa. Carbohydr Res, 141, 111-119.
24. Inoue A., Kodama N., and Nanba H. 2001. Effect of Maitake (Grifola frondosa) D-fraction on the control of the T lymph node Th-1/Th-2 proportion. Biol Pharm Bull, 25, 536-540.
25. Ishibashi K., Miura N. N., Adachi Y., and Ohno N. 2001. Relationship between solubility of grifolan, a fungal 1,3-β-D- glucan, and production of tumor necrosis factor by macrophages in vitro. Biosci Biotechnol Biochem, 65, 1993-2000.
26. Jung K., Kim I. H., and Han D. 2004. Effect of medicinal plant extracts on forced swimming capacity in mice. J Ethnopharmacol, 93, 75-81.
27. Kabir Y. and Kimura S. 1989. Dietary mushrooms reduce blood pressure in spontaneously hypertensive rats (SHR). J Nutr Sci Vitaminol (Tokyo), 35, 91-94.
28. Kabir Y., Yamaguchi M., and Kimura S. 1987. Effect of shiitake (Lentinus edodes) and maitake (Grifola frondosa) mushrooms on blood pressure and plasma lipids of spontaneously hypertensive rats. J Nutr Sci Vitaminol (Tokyo), 33, 341-346.
29. Kato K., Inagaki T., Shibagaki H., Yamauchi R., Okuda K., Sano T., and Ueno Y. 1983b. Structural analysis of the β-D-glucan extracted with aqueous zinc chloride from the fruit body of Grifola frondosa. Carbohydr Res, 123, 259-265.
30. Kato K., Inagaki T., Teranishi T., Yamauchi R., Okuda K., and Sano T. 1983a. Structural analysis of the alkali-soluble β-D-glucan from the fruit body of Grifola frondosa. Carbohydr Res, 124, 247-252.
31. Kato K., Kawaguchi M., Kumada K., Yamauchi R., and Ueno Y. 1990. An alkali-soluble α-D-glucan from the fruiting body of Grifola frondosa. Carbohydr Res, 198, 149-152.
32. Kawagishi H., Nomura A., Mizuno T., Kimura A., and Chiba S. 1990. Isolation and characterization of lectin from Grifola frondosa fruiting bodies. Biochim Biophys Acta, 1034, 247-252.
33. Kawakami S., Kobayashi F., and Naito S. 1994. Culture medium for cultivating mushroom. Patent JP 6153692.
34. Kim Y. 2003. Introduction to Maitake, Grifola frondosa, cultivation. MushWorld [serial on the Internet], 2003 Jul 09. Available from: http:// www.mushworld.com/.
35. Kirchhoff B. 2004. Investigations in genotypes and substrates for the fruit body production of Grifola frondosa (Dicks.:Fr.) S.F. Gray. MushWorld [serial on the Internet], 2004 Jun 02, Available from: http://www.mushworld.com/.
36. Kodama N., Asakawa A., Inui A., Masuda Y., and Nanba H. 2005a. Enhancement of cytotoxicity of NK cells by D-fraction, a polysaccharide from Grifola frondosa. Oncol Rep, 13, 497-502.
37. Kodama N., Harada N., and Nanba H. 2002a. A polysaccharide extract from Grifola frondosa induces Th-1 dominant responses in carcinoma-bearing BALB/c mice. Jpn J Pharmacol, 90, 357-360.
38. Kodama N., Komuta K., and Nanba H. 2002b. Can Maitake MD-fraction aid cancer patients? Altern Med Rev, 7, 236-239.
39. Kodama N., Komuta K., and Nanba H. 2003. Effect of Maitake (Grifola frondosa) D-fraction on the activation of NK cells in cancer patients. J Med Food, 6, 371-377.
40. Kodama N., Murata Y., Asakawa A., Inui A., Hayashi M., Sakai N., and Nanba H. 2005b. Maitake D-fraction enhances antitumor effects and reduces immunosuppression by mitomycin-C in tumor-bearing mice. Nutrition, 21, 624-629.
41. Kodama N., Murata Y., and Nanba H. 2004. Administration of a polysaccharide from Grifola frondosa stimulates immune function of normal mice. J Med Food, 7, 141-145.
42. Kodama N., Yamada M., and Nanba H. 2001. Addition of Maitake D-fraction reduces the effective dosage of vancomycin for the treatment of Listeria-infected mice. Jpn J Pharmacol, 87, 327-332.
43. Kosuna K. 1998. Polysaccharides and preparation thereof. Patent US 5756318.
44. Kubo K., Aoki H., and Nanba H. 1994. Antidiabetic activity present in the fruit body of Grifola frondosa (Maitake). Biol Pharm Bull, 17, 1106-1110.
45. Kubo K. and Nanba H. 1996. The effect of Maitake mushrooms on liver and serum lipids. Altern Ther Health Med, 2, 62-66.
46. Kubo K. and Nanba H. 1997. Anti-hyperliposis effect of Maitake fruit body (Grifola frondosa). Biol Pharm Bull, 20, 781-785.
47. Kubo K. and Nanba H. 1998. Modification of cellular immune responses in experimental autoimmune hepatitis in mice by maitake (Grifola frondosa). Mycoscience, 39, 351-360.
48. Kurasige S., Akuzawa Y., and Endo F. 1997. Effects of Lentinus edodes, Grifola frondosa, and Pleurotus ostreatus administration on cancer outbreak, and activities of macrophages and lymphocytes in mice treated with a carcinogen, N-butyl-N-butanolnitrosoamine. Immunopharmacol Immunotoxicol, 19, 175-183.
49. Lee B. C., Bae J. T., Pyo H. B., Choe T. B., Kim S. W., Hwang H. J., and Yun J. W. 2003. Biological activities of the polysaccharides produced from submerged culture of the edible Basidiomycete Grifola frondosa. Enzyme Microbial Technol, 32, 574-581.
50. Lee B. C., Bae J. T., Pyo H. B., Choe T. B., Kim S. W., Hwang H. J., Won J., and Yun J. W. 2004. Submerged culture conditions for the production of mycelial biomass and exopolysaccharides by the edible Basidiomycete Grifola frondosa. Enzyme Microbial Technol, 35, 369-376.
51. Lin H., She Y. H., Cassileth B. R., Sirotnak F., and Cunningham R. S. 2004. Maitake beta-glucan MD-fraction enhances bone marrow colony formation and reduces doxorubicin toxicity in vitro. Int Immunopharmacol, 4, 91-99.
52. Lin J. T. and Liu W. H. 2006. O-orsellinaldehyde from the submerged culture of the edible mushroom Grifola frondosa exhibits selective cytotoxic effect against Hep 3B cells through apoptosis. J Agric Food Chem, 54, 7564-7569.
53. Manohar V., Talpur N. A., Echard B. W., Lieberman S., and Preuss H. G. 2002. Effects of a water-soluble extract of Maitake mushroom on circulating glucose/insulin concentrations in KK mice. Diabetes Obes Metab, 4, 43-48.
54. Masayuki O. 2003. Apparatus for cultivating Grifola frondosa. Patent JP 2003143950.
55. Matsui K., Kodama N., and Nanba H. 2001. Effects of Maitake (Grifola frondosa) D-fraction on the carcinoma angiogenesis. Cancer Lett, 172, 193-198.
56. Mau J. L., Chang C. N., and Huang S. J. 2004. Antioxidant properties of methanolic extracts from Grifola frondosa, Morchella esculenta, and Termitomyces albuminosus mycelia. Food Chem, 87, 111-118.
57. Mau J. L., Lin H. C., Ma J. T., and Song S. F. 2001. Non-volatile taste components of several speciality mushrooms. Food Chem, 73, 461-466.
58. Mau J. L., Lin H. C., Ma J. T., and Song S. F. 2002. Antioxidant properties of several specialty mushrooms. Food Rev Int, 35, 519-526.
59. Mayell M. 2001. Maitake extracts and their therapeutic potential - a review. Altern Med Rev, 6, 48-60.
60. Miura N. N., Ohno N., Aketagawa J., Tamura H., Tanaka S., and Yadomae T. 1996. Blood clearance of (1-3)-β-D-glucan in MRL lpr/lpr mice. FEMS Immunol Med Microbiol, 13, 51-57.
61. Mlinaric A., Kac J., and Pohleven F. 2005. Screening of selected wood-damaging fungi for the HIV-1 reverse transcriptase inhibitors. Acta Pharm, 55, 69-79.
62. Mueller A., Raptis J., Rice P. J., Kalbfleisch J. H., Stout R. D., Ensley H. E., Browder W., and Williams D. L. 2000. The influence of glucan polymer structure and solution conformation on binding to (1-3)-β- D-glucan receptors in a human monocytelike cell line. Glycobiology, 10, 339-346.
63. Nagai M. and Kusakabe K. 2000. Nutrient material for mushroom bed artificial cultivation of Grifola frondosa S. F. Gray. Patent JP 2000270675.
64. Nanba H. 1995. Activity of maitake D-fraction to inhibit carcinogenesis and metastasis. Ann N Y Acad Sci, 768, 243-245.
65. Nanba H. 2001. Infection preventing and treating agent derived from Grifola frondosa. Patent JP 2001072601.
66. Nanba H., Kodama N., Schar D., and Turner D. 2000. Effects of G. frondosa (Grifola frondosa) glucan in HIV-infected patients. Mycoscience, 41, 293-295.
67. Nanba H. and Kubo K. 1997. Effect of Maitake Dfraction on cancer prevention. Ann N Y Acad Sci, 833, 204-207.
68. Nanba H. and Kubo K. 1998. Antitumor substance extracted from Grifola. Patent US 5854404.
69. Nanba K., Yamazaki T., and Mizuno M. 2002. Method for culturing Grifola frondosa and cap for bottle for culturing Grifola fondosa used in the same method. Patent JP 2002218844.
70. Nie X., Shi B., Ding Y., and Tao W. 2006. Preparation of a chemically sulfated polysaccharide derived from Grifola frondosa and its potential biological activities. Int J Biol Macromol, 39, 228-233.
71. Nishiwaki T. and Hayashi K. 2001. Purification and characterization of an aminopeptidase from the edible basidiomycete Grifola frondosa. Biosci Biotechnol Biochem, 65, 424-427.
72. Nishiwaki T., Yoshimizu S., Furuta M., and Hayashi K. 2002. Debittering of enzymatic hydrolysates using an aminopeptidase from the edible basidiomycete Grifola frondosa. J Biosci Bioeng, 93, 60-63.
73. Okazaki M., Adachi Y., Ohno N., and Yadomar T. 1995. Structure-activity relationship of (1-3)-beta-D-glucans in the induction of cytokine production from macrophages in vitro. Biol Pharm Bull, 18, 1320-1327.
74. Pero R. W., Amiri A., Sheng Y., Welther M., and Rich M. 2005. Formulation and in vitro/in vivo evaluation of combining DNA repair and immune enhancing nutritional supplements. Phytomedicine, 12, 255-263.
75. Royse D. J. 1996. Speciality mushrooms. In: Progress in new crops, Janick J., ed., ASHS Press, Arlington, VA, pp. 446-475.
76. Shen Q. 2001. Molecular phylogenetic analysis of Grifola frondosa (Maitake) and related species and the influence of selected nutrient supplements on mushroom yield. Ph.D. Thesis. Pennsylvania State University, The Graduate School, University Park, PA.
77. Shen Q. 2003. Crop cycle time, yield and quality of maitake Grifola frondosa as influenced by nutrient supplements. MushWorld [serial on the Internet], 2003-12-06, Available from: http://www.mushworld. com/.
78. Shigeki N., Hideko N., Yukiko O., and Naoko M. 1996. Sheet for Grifola frondosa cultivation and method for the cultivation. Patent JP 8317726.
79. Shigesue K., Kodama N., and Nanba H. 2000. Effects of maitake (Grifola frondosa) polysaccharide on collagen-induced arthritis in mice. Jpn J Pharmacol, 84, 293-300.
80. Shimaoka I., Kodama J., Nishino K., and Itokawa Y. 1993. Purification of a copper binding peptide from the mushroom Grifola frondosa and its effects on copper absorption. J Nutr Biochem, 4, 33-38.
81. Shimizu M. 1989. Method for culturing and cultivating fungi. Patent US 4878312.
82. Someya N. and Someya S. 2001. Coral sand containing culture medium for artificial cultivation of mushroom. Patent JP 2001136832
83. Stamets P. 2000. Maitake of Hen-of-the-Woods Grifola frondosa (Dicks.: Fr.) S.F. Gray. In: Growing Gourmet and Medicinal Mushrooms. 3rd ed. Ten Speed Press, Berkeley, CA, pp. 367-376.
84. Stott K. and Mohammed C. 2004. Specialty mushroom production systems: Maitake and morels. A report for the Rural Industries Research and Development Corporation, March 2004, Australian government, RIRDC Publication No 04/024, ISBN 0 642 58734 5.
85. Suzuki I., Hashimoto K., Oikawa S., Sato K., Osawa M., and Yadomae T. 1989. Antitumor and immunomodulating activities of a beta-glucan obtained from liquid cultured Grifola frondosa. Chem Pharm Bull, 37, 410-413.
86. Suzuki N., Nishibori K., Oodaira Y., Kitamura S., Michigami K., Nagata K., Tatara Y., Lee B. R., and Ichishima E. 2005. Grifolisin, a member of the sedolisin family produced by the fungus Grifola frondosa. Phytochemistry, 66, 983-990.
87. Suzuki Y., Adachi Y., Ohno N., and Yadomae T. 2001. Th1/Th2-balancing immunomodulating activity of gel-forming (1-3)-β-glucans from fungi. Biol Pharm Bull, 24, 811-819.
88. Talpur N. A., Echard B. W., Fan A. Y., Jaffari O., Bagchi D., and Preuss H. G. 2002. Antihypertensive and metabolic effects of whole Maitake mushroom powder and its fractions in two rat strains. Mol Cell Biochem, 237, 129-136.
89. Tazawa K., Odaira Y., and Watanabe M. 2003. Active oxygen scavenger and cancer chemopreventer from Grifola. Patent US 6616928.
90. Uchiyama M., Ohno N., Miura N. N., Adachi Y., and Yadomae T. 2002. Anti-grifolan antibody reacts with the cell wall β-glucan and the extracellular mannoprotein-β-glucan complex of C. albicans. Carbohydr Polym, 48, 333-340.
91. Usui S., Matsunaga T., Ukai S., Kiho T., Hirano K., 1999. Growth suppressing factor for endothelial cells exhibits tumor regressing activity. Biol Pharm Bull, 22, 353-359
92. Wu M. J., Cheng T. L., Cheng S. Y., Lian T. W., Wang L., and Chiou S. Y. 2006. Immunomodulatory properties of Grifola frondosa in submerged culture. J Agric Food Chem, 54, 2906-2914.
93. Wu S., Zou D., Han S. H., et al. 1994. Therapeutic effect of Grifola polysaccharides in chronic hepatitis B [abstract P-18]. In: International Symposium on Production and Products of Lentinus Mushroom, Programme and Abstract, Qingyuan, Zhejiang Province, China. International Society for Mushroom Science, Committee on Science, Asian Region, Qingyuan County Government, Zhejiang Province, China, 1994.
94. Yan J., Vetvicka V., Xia Y., Hanikyrova M., Mayadas T. N., and Ross G. D. 2000. Critical role of Kupffer cell CR3 (CD11b/CD18) in the clearance of IgM-opsonized erythrocytes or soluble β-glucan. Immunopharmacology, 46, 39-54.
95. Yokota M. 1992. Observatory trial of anti-obesity activity of maitake mushroom (Grifola frondosa). Anshin, 1992, 202-203.
96. Yoshikawa M. 1989. Agent for inducing formation of fruit body of mushrooms. Patent JP 1254606.
97. Yoshikawa M. and Oga Y. 1989. Growth promoting agent for mushrooms. Patent JP 1186802.
98. Zhou C. and Wasser S.P. 2004. Medicinal value of culinary-medicinal maitake mushroom Grifola frondosa (Dicks.:Fr.) S.F. Gray (Aphyllo-phoromycetideae). Review. Int J Med Mushr, 6, 287-313.
99. Zhu Y. 2006. Health promoting dairy and food products containing mushroom glucan produced through fermentation of Grifola frondosa. Patent EP 1709969 A1.